186 related articles for article (PubMed ID: 27354448)
21. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Terra L; Lee Meeuw Kjoe PR; Agelink van Rentergem JA; Beekman MJ; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Mourits MJE; van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; van der Wall E; van Leeuwen FE; Schagen SB
BJOG; 2023 Jul; 130(8):968-977. PubMed ID: 36715559
[TBL] [Abstract][Full Text] [Related]
22. Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
Nebgen DR; Domchek SM; Kotsopoulos J; de Hullu JA; Crosbie EJ; Paramanandam VS; Brood-van Zanten MMA; Norquist BM; Guise T; Rozenberg S; Kurian AW; Pederson HJ; Yuksel N; Michaelson-Cohen R; Bober SL; da Silva Filho AL; Johansen N; Guidozzi F; Evans DG; Menon U; Kingsberg SA; Powell CB; Grandi G; Marchetti C; Jacobson M; Brennan DJ; Hickey M
BJOG; 2023 Nov; 130(12):1437-1450. PubMed ID: 37132126
[TBL] [Abstract][Full Text] [Related]
23. Surgical decision making in premenopausal
Gaba F; Goyal S; Marks D; Chandrasekaran D; Evans O; Robbani S; Tyson C; Legood R; Saridogan E; McCluggage WG; Hanson H; Singh N; Evans DG; Menon U; Manchanda R;
J Med Genet; 2022 Feb; 59(2):122-132. PubMed ID: 33568437
[TBL] [Abstract][Full Text] [Related]
24. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in
Philpott S; Raikou M; Manchanda R; Lockley M; Singh N; Scott M; Evans DG; Adlard J; Ahmed M; Edmondson R; Woodward ER; Lamnisos A; Balega J; Brady AF; Sharma A; Izatt L; Kulkarni A; Tripathi V; Solomons JS; Hayes K; Hanson H; Snape K; Side L; Skates S; McGuire A; Rosenthal AN
J Med Genet; 2023 May; 60(5):440-449. PubMed ID: 36319079
[TBL] [Abstract][Full Text] [Related]
25. Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
Hurry M; Eccleston A; Dyer M; Hoskins P
Int J Technol Assess Health Care; 2020 Apr; 36(2):104-112. PubMed ID: 32423520
[TBL] [Abstract][Full Text] [Related]
26. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention.
Guo F; Adekanmbi V; Hsu CD; Berenson AB; Kuo YF; Shih YT
JAMA Netw Open; 2024 Feb; 7(2):e2356078. PubMed ID: 38353949
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Manchanda R; Patel S; Antoniou AC; Levy-Lahad E; Turnbull C; Evans DG; Hopper JL; Macinnis RJ; Menon U; Jacobs I; Legood R
Am J Obstet Gynecol; 2017 Nov; 217(5):578.e1-578.e12. PubMed ID: 28690137
[TBL] [Abstract][Full Text] [Related]
29. Ovarian preservation compared to oophorectomy in premenopausal women with early-stage, low-grade endometrial Cancer: A cost-effectiveness analysis.
Hernandez-Zepeda ML; Munro EG; Caughey AB; Bruegl AS
Gynecol Oncol; 2023 Jun; 173():8-14. PubMed ID: 37030073
[TBL] [Abstract][Full Text] [Related]
30. Economic Evaluation of Population-Based
Manchanda R; Sun L; Patel S; Evans O; Wilschut J; De Freitas Lopes AC; Gaba F; Brentnall A; Duffy S; Cui B; Coelho De Soarez P; Husain Z; Hopper J; Sadique Z; Mukhopadhyay A; Yang L; Berkhof J; Legood R
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708835
[TBL] [Abstract][Full Text] [Related]
31. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
[TBL] [Abstract][Full Text] [Related]
32. Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer.
Simoes Correa-Galendi J; Del Pilar Estevez Diz M; Stock S; Müller D
Appl Health Econ Health Policy; 2021 Jan; 19(1):97-109. PubMed ID: 32537695
[TBL] [Abstract][Full Text] [Related]
33. Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.
Liu YL; Breen K; Catchings A; Ranganathan M; Latham A; Goldfrank DJ; Grisham RN; Long Roche K; Frey MK; Chi DS; Abu-Rustum N; Aghajanian C; Offit K; Stadler ZK
JCO Oncol Pract; 2022 Mar; 18(3):201-209. PubMed ID: 34582274
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China.
Sun L; Cui B; Wei X; Sadique Z; Yang L; Manchanda R; Legood R
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406611
[TBL] [Abstract][Full Text] [Related]
35. Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.
Ferrandina G; Amadio G; Marcellusi A; Azzolini E; Puggina A; Pastorino R; Ricciardi W; Scambia G
Clin Drug Investig; 2017 Nov; 37(11):1093-1102. PubMed ID: 28895089
[TBL] [Abstract][Full Text] [Related]
36. Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations.
Hallsson LR; Sroczynski G; Engel J; Siebert U
BMC Cancer; 2023 Jun; 23(1):590. PubMed ID: 37365514
[TBL] [Abstract][Full Text] [Related]
37. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
[TBL] [Abstract][Full Text] [Related]
38. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.
Grandi G; Sammarini M; Cortesi L; Toss A; Botticelli L; Varliero F; Sighinolfi G; Barbieri E; Facchinetti F
Menopause; 2021 Feb; 28(3):263-270. PubMed ID: 33534430
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
[TBL] [Abstract][Full Text] [Related]
40. Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study.
Terra L; Heemskerk-Gerritsen BAM; Beekman MJ; Engelhardt E; Mourits MJE; van Doorn HC; de Hullu JA; Mom CH; Slangen BFM; Gaarenstroom KN; van Beurden M; Roeters Van Lennep JE; van Dorst EBL; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Steensma AB; van Leeuwen FE
BJOG; 2024 Jan; 131(1):99-108. PubMed ID: 37394722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
